1-(3-cyclopropyl-1,4-dimethylpyrazolo[5,4-b]pyridin-6-yl)oxy-4-(4-methyl-2-pyridinyl)pentan-2-one
C22H26N4O2 — CID 157427721
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3-cyclopropyl-1,4-dimethylpyrazolo[5,4-b]pyridin-6-yl)oxy-4-(4-methyl-2-pyridinyl)pentan-2-one
1-(3-cyclopropyl-1,4-dimethylpyrazolo[5,4-b]pyridin-6-yl)oxy-4-(4-methyl-2-pyridinyl)pentan-2-one (PubChem CID 157427721) has the molecular formula C22H26N4O2 and a molecular weight of 378.48 g/mol. Its IUPAC name is 1-(3-cyclopropyl-1,4-dimethylpyrazolo[5,4-b]pyridin-6-yl)oxy-4-(4-methyl-2-pyridinyl)pentan-2-one.
Molecular Properties
| Compound Name | 1-(3-cyclopropyl-1,4-dimethylpyrazolo[5,4-b]pyridin-6-yl)oxy-4-(4-methyl-2-pyridinyl)pentan-2-one |
|---|---|
| PubChem CID | 157427721 |
| Molecular Formula | C22H26N4O2 |
| Molecular Weight | 378.48 g/mol |
| Exact Mass | 378.21 |
| IUPAC Name | 1-(3-cyclopropyl-1,4-dimethylpyrazolo[5,4-b]pyridin-6-yl)oxy-4-(4-methyl-2-pyridinyl)pentan-2-one |
| SMILES | Cc1ccnc(C(C)CC(=O)COc2cc(C)c3c(C4CC4)nn(C)c3n2)c1 |
| InChI | InChI=1S/C22H26N4O2/c1-13-7-8-23-18(9-13)14(2)10-17(27)12-28-19-11-15(3)20-21(16-5-6-16)25-26(4)22(20)24-19/h7-9,11,14,16H,5-6,10,12H2,1-4H3 |
| InChIKey | BQDTYRMCTXXXAR-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 69.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 378.48 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157427721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.